Massachusetts Financial Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-188,444
| Closed | -$9.59M | – | 982 |
|
|
2025
Q4 | $9.59M | Buy |
188,444
+14
| +0% | +$716 | ﹤0.01% | 720 |
|
|
2025
Q3 | $10.5M | Buy |
188,430
+21,457
| +13% | +$1.26M | ﹤0.01% | 686 |
|
|
2025
Q2 | $11.5M | Buy |
166,973
+25,920
| +18% | +$1.76M | ﹤0.01% | 670 |
|
|
2025
Q1 | $9.79M | Buy |
141,053
+40,945
| +41% | +$3.38M | ﹤0.01% | 662 |
|
|
2024
Q4 | $8.61M | Buy |
100,108
+20,448
| +26% | +$2.21M | ﹤0.01% | 660 |
|
|
2024
Q3 | $9.49M | Buy |
79,660
+2,166
| +3% | +$289K | ﹤0.01% | 642 |
|
|
2024
Q2 | $11.1M | Buy |
77,494
+1,860
| +2% | +$246K | ﹤0.01% | 630 |
|
|
2024
Q1 | $9.71M | Buy |
75,634
+2,775
| +4% | +$330K | ﹤0.01% | 627 |
|
|
2023
Q4 | $7.54M | Sell |
72,859
-800,735
| -92% | -$79.2M | ﹤0.01% | 638 |
|
|
2023
Q3 | $79.4M | Sell |
873,594
-719,472
| -45% | -$63.4M | 0.03% | 385 |
|
|
2023
Q2 | $129M | Buy |
1,593,066
+1,513,672
| +1,907% | +$124M | 0.04% | 323 |
|
|
2023
Q1 | $6.32M | Buy |
79,394
+3,542
| +5% | +$251K | ﹤0.01% | 634 |
|
|
2022
Q4 | $5.13M | Sell |
75,852
-15,586
| -17% | -$914K | ﹤0.01% | 653 |
|
|
2022
Q3 | $4.55M | Sell |
91,438
-5,212
| -5% | -$279K | ﹤0.01% | 657 |
|
|
2022
Q2 | $5.38M | Sell |
96,650
-11,966
| -11% | -$664K | ﹤0.01% | 648 |
|
|
2022
Q1 | $6.03M | Buy |
108,616
+6,862
| +7% | +$352K | ﹤0.01% | 667 |
|
|
2021
Q4 | $5.7M | Sell |
101,754
-45,486
| -31% | -$2.46M | ﹤0.01% | 696 |
|
|
2021
Q3 | $7.07M | Sell |
147,240
-84,840
| -37% | -$4.1M | ﹤0.01% | 689 |
|
|
2021
Q2 | $9.72M | Buy |
232,080
+13,802
| +6% | +$535K | ﹤0.01% | 674 |
|
|
2021
Q1 | $7.36M | Buy |
218,278
+26,926
| +14% | +$959K | ﹤0.01% | 678 |
|
|
2020
Q4 | $6.68M | Buy |
191,352
+6,664
| +4% | +$230K | ﹤0.01% | 661 |
|
|
2020
Q3 | $6.41M | Buy |
184,688
+6,390
| +4% | +$213K | ﹤0.01% | 656 |
|
|
2020
Q2 | $5.84M | Sell |
178,298
-33,472
| -16% | -$1.07M | ﹤0.01% | 634 |
|
|
2020
Q1 | $6.37M | Buy |
211,770
+13,434
| +7% | +$400K | ﹤0.01% | 623 |
|
|
2019
Q4 | $5.74M | Buy |
198,336
+2,872
| +1% | +$79.5K | ﹤0.01% | 634 |
|
|
2019
Q3 | $5.05M | Sell |
195,464
-7,400
| -4% | -$187K | ﹤0.01% | 656 |
|
|
2019
Q2 | $5.18M | Buy |
202,864
+2,930
| +1% | +$72.4K | ﹤0.01% | 667 |
|
|
2019
Q1 | $5.23M | Buy |
199,934
+23,632
| +13% | +$581K | ﹤0.01% | 660 |
|
|
2018
Q4 | $4.06M | Sell |
176,302
-5,390
| -3% | -$120K | ﹤0.01% | 669 |
|
|
2018
Q3 | $4.28M | Sell |
181,692
-2,042
| -1% | -$49.8K | ﹤0.01% | 679 |
|
|
2018
Q2 | $4.24M | Buy |
183,734
+1,732
| +1% | +$41.2K | ﹤0.01% | 678 |
|
|
2018
Q1 | $4.48M | Buy |
182,002
+42,462
| +30% | +$1.11M | ﹤0.01% | 670 |
|
|
2017
Q4 | $3.75M | Buy |
139,540
+6,290
| +5% | +$160K | ﹤0.01% | 677 |
|
|
2017
Q3 | $3.21M | Buy |
+133,250
| New | +$3.01M | ﹤0.01% | 679 |
|
Other funds holding NVO
DAM
F
Massachusetts Financial Services's NVO Position: Q1 2026 in Review
Massachusetts Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 188,444 shares — an estimated $9.59M sold.
Massachusetts Financial Services first reported a position in NVO in Q3 2017 and held it in 34 quarters. The position peaked at $129M in Q2 2023. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Massachusetts Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Massachusetts Financial Services sold 188,444 Novo Nordisk shares in Q1 2026, an estimated $9.59M.
- Massachusetts Financial Services first reported a position in Novo Nordisk in Q3 2017 and held it in 34 quarters.
- Massachusetts Financial Services's Novo Nordisk position peaked at $129M in Q2 2023.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.